Literature DB >> 1831680

Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

D D Poutsiaka1, B D Clark, E Vannier, C A Dinarello.   

Abstract

We studied the relationship between the production of the 23-Kd interleukin-1 receptor antagonist (IL-1ra) and IL-1 beta in cultures of human peripheral blood mononuclear cells (PBMC) using a specific radioimmunoassay for IL-1ra that had a sensitivity of 166 +/- 11 pg/mL. PBMC cultured without human serum made little IL-1ra or IL-1 beta. In the presence of 1% AB serum, there was no increase in IL-1 beta (0.25 +/- 0.13 ng/mL) but IL-1ra production increased sevenfold to 3.4 +/- 0.5 ng/mL. IgG (2.5 to 100 micrograms/mL IgG) or granulocyte-macrophage colony-stimulating factor (GM-CSF) (1 to 100 ng/mL) had no significant effect on IL-1 beta production but increased IL-1ra production up to 18-fold (18.2 +/- 3.9 ng/mL). Using endotoxin as a stimulant, 82% +/- 2% of IL-1ra was secreted in comparison with 52% +/- 9% of IL-1 beta. Culture conditions of PBMC influenced the production of IL-1ra but not IL-1 beta. Rocking endotoxin-stimulated PBMC produced 75% less IL-1ra but the same amount of IL-1 beta when compared with PBMC cultured in stationary plastic tubes. Rocking IgG-or GM-CSF-stimulated PBMC also produced 75% to 80% less IL-1ra. GM-CSF or IL-1 beta at concentrations that elicited submaximal production of IL-1ra potentiated IgG-induced IL-1ra production. The production of IL-1ra and IL-1 beta are under differential regulation because serum, IgG, and GM-CSF were potent stimuli for the production of IL-1ra but not IL-1 beta, and the prevention of cell-cell contact of PBMC reduced IL-1ra but not IL-1 beta production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831680

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  Mitochondrial DNA injury and mortality in hemodialysis patients.

Authors:  Madhumathi Rao; Lijun Li; Caren Demello; Daqing Guo; Bertrand L Jaber; Brian J G Pereira; Vaidyanathapuram S Balakrishnan
Journal:  J Am Soc Nephrol       Date:  2008-08-06       Impact factor: 10.121

2.  Lipopolysaccharide and Raf-1 kinase regulate secretory interleukin-1 receptor antagonist gene expression by mutually antagonistic mechanisms.

Authors:  C J Guthridge; D Eidlen; W P Arend; A Gutierrez-Hartmann; M F Smith
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function.

Authors:  Donald Cheatem; Balaji B Ganesh; Eryn Gangi; Chenthamarakshan Vasu; Bellur S Prabhakar
Journal:  Clin Immunol       Date:  2009-01-25       Impact factor: 3.969

4.  Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Authors:  F W Tam; J Smith; S J Cashman; Y Wang; E M Thompson; A J Rees
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

5.  Genetic Variation in Toll-Interacting Protein Is Associated With Leprosy Susceptibility and Cutaneous Expression of Interleukin 1 Receptor Antagonist.

Authors:  Javeed A Shah; William R Berrington; James C Vary; Richard D Wells; Glenna J Peterson; Chhatra B Kunwar; Saraswoti Khadge; Deanna A Hagge; Thomas R Hawn
Journal:  J Infect Dis       Date:  2015-11-26       Impact factor: 5.226

6.  Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist.

Authors:  E Vannier; C A Dinarello
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice.

Authors:  M T Vogels; C C Hermsen; H L Huys; W M Eling; J W van der Meer
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Authors:  L C Miller; S Isa; E Vannier; K Georgilis; A C Steere; C A Dinarello
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.

Authors:  K Aiura; J A Gelfand; J F Burke; R C Thompson; C A Dinarello
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.